[ 177 Lu]Lu-PSMA-617 theranostic probe for hepatocellular carcinoma imaging and therapy.
Qiaomiao LuYu LongYongkang GaiQingyao LiuDawei JiangXiaoli LanPublished in: European journal of nuclear medicine and molecular imaging (2023)
Lu]Lu-EB-PSMA-617 significantly suppressed tumor growth and prolonged survival time in PSMA-positive HCC xenograft mice without obvious toxicity. These radioligands appear promising for clinical use in humans, and future studies are warranted.